HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masaaki Teranishi Selected Research

Meniere Disease (Menieres Disease)

8/2021Evaluation of the blood-perilymph barrier in ears with endolymphatic hydrops.
2/2021Imaging of endolymphatic hydrops on a vertigo attack of Meniere's disease.
7/2018The relationship between endolymphatic hydrops in the vestibule and low-frequency air-bone gaps.
6/2013Association between polymorphisms in genes encoding methylenetetrahydrofolate reductase and the risk of Ménière's disease.
3/2013Polymorphisms in genes encoding aquaporins 4 and 5 and estrogen receptor α in patients with Ménière's disease and sudden sensorineural hearing loss.
10/2012Polymorphisms in genes involved in oxidative stress response in patients with sudden sensorineural hearing loss and Ménière's disease in a Japanese population.
3/2012Contrast enhancement of the inner ear in magnetic resonance images taken at 10 minutes or 4 hours after intravenous gadolinium injection.
10/2011Contrast enhancement of the inner ear after intravenous administration of a standard or double dose of gadolinium contrast agents.
5/2011Endolymphatic hydrops and blood-labyrinth barrier in Ménière's disease.
3/2010Endolymphatic hydrops revealed by intravenous gadolinium injection in patients with Ménière's disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masaaki Teranishi Research Topics

Disease

15Endolymphatic Hydrops
08/2021 - 02/2009
12Meniere Disease (Menieres Disease)
08/2021 - 03/2007
11Sensorineural Hearing Loss
08/2018 - 03/2007
7Hearing Loss (Hearing Impairment)
02/2022 - 12/2009
5Labyrinth Diseases
03/2012 - 03/2007
4Otosclerosis
12/2018 - 12/2013
3Vertigo (Positional Vertigo)
12/2011 - 12/2009
3Hemorrhage
08/2008 - 05/2006
2Hypertension (High Blood Pressure)
11/2013 - 09/2012
2Inflammation (Inflammations)
11/2013 - 09/2012
2Paralysis (Palsy)
11/2013 - 05/2010
2Dyslipidemias (Dyslipidemia)
11/2013 - 09/2012
2Sudden Hearing Loss (Sudden Deafness)
01/2012 - 06/2010
2Apnea
01/2010 - 05/2009
2Sleep Apnea Syndromes (Sleep Apnea)
05/2009 - 01/2008
2Nasal Obstruction
05/2009 - 01/2008
2Obstructive Sleep Apnea
01/2008 - 03/2007
1Cognitive Dysfunction
02/2022
1Ear Diseases (Disease, Ear)
08/2021
1Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
04/2021
1Vitamin D Deficiency
01/2019
1Benign Paroxysmal Positional Vertigo
01/2019
1Postoperative Hemorrhage
02/2014
1Surgical Wound Infection
02/2014
1Diabetic Neuropathies (Diabetic Neuropathy)
11/2013
1Facial Paralysis (Facial Palsy)
11/2013
1Diabetic Nephropathies (Diabetic Nephropathy)
11/2013
1Cardiovascular Diseases (Cardiovascular Disease)
06/2013
1Neoplasms (Cancer)
06/2013
1Macular Degeneration (Age-Related Maculopathy)
05/2012
1Hereditary Hemorrhagic Telangiectasia
05/2012
1Tinnitus
01/2012
1Goiter
06/2011
1Deafness (Deaf Mutism)
06/2011
1Pendred syndrome
06/2011
1Epstein-Barr Virus Infections
01/2011
1Infections
01/2011
1Bell Palsy (Bell's Palsy)
05/2010
1Herpes Zoster Oticus (Geniculate Neuralgia)
05/2010
1Disorders of Excessive Somnolence (Hypersomnia)
01/2008

Drug/Important Bio-Agent (IBA)

18GadoliniumIBA
08/2021 - 03/2007
3Contrast MediaIBA
08/2021 - 02/2011
3gadodiamide (Omniscan)FDA Link
03/2012 - 02/2011
3gadoteridol (Prohance)FDA Link
10/2011 - 03/2010
2ORALIT (ORS)IBA
11/2013 - 09/2012
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2012 - 12/2009
2Gadolinium DTPA (Magnevist)FDA Link
02/2011 - 12/2009
2Gentamicins (Gentamicin)FDA LinkGeneric
08/2009 - 03/2007
2SteroidsIBA
08/2009 - 03/2007
2Proteins (Proteins, Gene)FDA Link
08/2008 - 08/2006
1Vitamin DFDA LinkGeneric
01/2019
1Uncoupling Protein 2IBA
08/2018
1Indicators and Reagents (Reagents)IBA
07/2018
1Analgesics (Analgesic Drugs)IBA
02/2014
1Cefazolin (Ancef)FDA LinkGeneric
02/2014
1Azithromycin (Zithromax)FDA LinkGeneric
02/2014
1CreatinineIBA
11/2013
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2013
1Endothelin-1 (Endothelin 1)IBA
11/2013
1Folic Acid (Vitamin M)FDA LinkGeneric
06/2013
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
06/2013
1Aquaporins (Water Channels)IBA
03/2013
1Aquaporin 4IBA
03/2013
1Estrogen ReceptorsIBA
03/2013
1Aquaporin 5IBA
03/2013
1superoxide dismutase 2IBA
10/2012
1Aryldialkylphosphatase (Paraoxonase)IBA
10/2012
1Glutathione Peroxidase GPX1IBA
10/2012
1Vascular Endothelial Growth Factor CIBA
09/2012
1Interleukin-10 (Interleukin 10)IBA
09/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2012
1Interleukin-6 (Interleukin 6)IBA
09/2012
1Complement Factor H (Factor H)IBA
05/2012
1EndoglinIBA
05/2012
1Activins (Activin)IBA
05/2012
1Phosphotransferases (Kinase)IBA
05/2012
1Dihydrotachysterol (AT 10)IBA
03/2012
1Pentetic Acid (DTPA)FDA LinkGeneric
10/2011
1IodineIBA
06/2011
1MeglumineFDA Link
02/2011
1DNA (Deoxyribonucleic Acid)IBA
01/2011
1Antiviral Agents (Antivirals)IBA
01/2011
1enhanced green fluorescent proteinIBA
01/2011
1Oxygen (Dioxygen)IBA
01/2010
1Pharmaceutical PreparationsIBA
08/2009

Therapy/Procedure

3Stapes Surgery (Stapedectomy)
12/2018 - 08/2015
3Intratympanic Injection
01/2012 - 12/2009
3Therapeutics
12/2009 - 03/2007
2Hearing Aids (Hearing Aid)
02/2022 - 01/2021
2Intravenous Injections
02/2021 - 03/2017
2Tonsillectomy
02/2014 - 03/2007
2Nasal Surgical Procedures
05/2009 - 01/2008
2Drug Therapy (Chemotherapy)
02/2009 - 03/2007
1Cochlear Implantation
04/2021
1Oral Administration
02/2014
1Intravenous Administration
02/2014
1Lasers (Laser)
12/2013
1Injections
01/2012
1Laryngoscopes
12/2009
1Catheters
12/2009